Search Results for: asterias

Advanced Cell Technology pub: Trial for Macular Degeneration

February 1, 2021 / By / 8 Comments
ACT-FIgure-1-

The stem cell biotech Advanced Cell Technology (ACT) reported new, positive data in a paper in Lancet from their clinical trials using retinal pigmented epithelial cells (RPEs) made from human embryonic stem cells (hESC) for treatment of different forms of macular degeneration (MD). The paper was entitled “Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related …

Advanced Cell Technology pub: Trial for Macular Degeneration Read More »

Great 2nd Place ISSCR Essay Related to Vision and Stem Cells

February 1, 2021 / By
Hikita2smaller

ISSCR and I held a short essay contest for a free registration to ISSCR 2014 in Vancouver. The winning piece was written by student Mohamed Gatie, but there was a great 2nd place essay by Sherry Hikita that deserved acknowledgment. I’m publishing that essay below and Sherry will be receiving a free signed copy of my book and a free stem cell …

Great 2nd Place ISSCR Essay Related to Vision and Stem Cells Read More »

Dozen Candidates To Be New CIRM President

February 1, 2021 / By / 2 Comments
CIRM-

Who might make a fantastic new CIRM President? The California stem cell community is abuzz with this question. This new President will not only lead CIRM today, but also in all likelihood will steer CIRM in its new incarnation after 2017, what I’ve called CIRM 2.0. At least that would be ideal. CIRM has posted a …

Dozen Candidates To Be New CIRM President Read More »

Bad news as Geron to quit hESC SCI trial for financial reasons

February 1, 2021 / By / 6 Comments
Geron-300x2212

Reportedly, Geron has decided to only focus on cancer research and for financial reasons has shut down its hESC trial for spinal cord injury. This is a very sad day for stem cell science. (Update in 2020: the firm still exists, but is working in different areas. The stock has struggled.) No more spinal cord …

Bad news as Geron to quit hESC SCI trial for financial reasons Read More »